Klaus Berger

1.9k total citations
15 papers, 861 citations indexed

About

Klaus Berger is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Klaus Berger has authored 15 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Klaus Berger's work include Acute Ischemic Stroke Management (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Stroke Rehabilitation and Recovery (2 papers). Klaus Berger is often cited by papers focused on Acute Ischemic Stroke Management (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Stroke Rehabilitation and Recovery (2 papers). Klaus Berger collaborates with scholars based in Germany, United States and Austria. Klaus Berger's co-authors include Julie E. Buring, Carlos S. Kase, Umed A. Ajani, Charles H. Hennekens, Robert J. Glynn, J. Michael Gaziano, Paul M. Ridker, JoAnn E. Manson, Christopher J. O’Donnell and Robert J. Glynn and has published in prestigious journals such as New England Journal of Medicine, Circulation and Stroke.

In The Last Decade

Klaus Berger

15 papers receiving 816 citations

Peers

Countries citing papers authored by Klaus Berger

Since Specialization

Citations

This map shows the geographic impact of Klaus Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Berger more than expected).

Fields of papers citing papers by Klaus Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Berger. The network helps show where Klaus Berger may publish in the future.

Co-authorship network of co-authors of Klaus Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Berger. A scholar is included among the top collaborators of Klaus Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Berger. Klaus Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care 2021 ·Multiple Sclerosis Journal ·(unknown), David Ellenberger, Paulus Rommer, Alexander Stahmann, Uwe K. Zettl, Klaus Berger	19
2	Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis 2017 ·Stroke ·Sebastian Bellwald, Ralph Weber, Tomas Dobrocky, Hannes Nordmeyer, Simon Jung, Jeffrie Hadisurya, Pasquale Mordasini, Marie‐Luise Mono, Christian Paul Stracke, Hakan Sarıkaya, Corrado Bernasconi, Klaus Berger, Marcel Arnold, René Chapot, Jan Gralla, Urs Fischer	58
3	CKD and Acute and Long-Term Outcome of Patients with Peripheral Artery Disease and Critical Limb Ischemia 2015 ·Clinical Journal of the American Society of Nephrology ·Florian Lüders, Holger Bunzemeier, Christiane Engelbertz, Nasser Malyar, Matthias Meyborg, N. Roeder, Klaus Berger, Holger Reinecke	64
4	Peripheral Arterial Disease as an Independent Predictor for Excess Stroke Morbidity and Mortality in Primary-Care Patients: 5-Year Results of the getABI Study 2010 ·Cerebrovascular Diseases ·Saskia H. Meves, Curt Diehm, Klaus Berger, David Pittrow, Hans J. Trampisch, Ina Burghaus, Gerhart Tepohl, Jens‐Rainer Allenberg, Heinz G. Endres, Markus Schwertfeger, Harald Darius, Roman L. Haberl, (unknown)	77
5	CAG repeats in restless legs syndrome 2006 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Markus Rafael Konieczny, Peter Bauer, Jürgen Tomiuk, (unknown), J. Haan, Klaus Berger, Olaf Rieß, Lüdger Schöls	19
6	International Experience in Stroke Registries 2006 ·American Journal of Preventive Medicine ·Peter U. Heuschmann, Klaus Berger	12
7	Relation of Plasma Thyroid-Stimulating Hormone Levels to Vascular Lesions and Atrophy of the Brain in the Elderly 2006 ·Neuroepidemiology ·Christiane Reitz, (unknown), Andreas Roesler, Arnold von Eckardstein, Klaus Berger	2
8	Development and Implementation of Evidence-Based Indicators for Measuring Quality of Acute Stroke Care 2006 ·Stroke ·Peter U. Heuschmann, (unknown), O. Busse, Susanne Elsner, Armin Grau, (unknown), P Hermanek, Rudolf Janzen, Peter L. Kolominsky‐Rabas, Klaus Kraywinkel, К. Lowitzsch, B. Misselwitz, Darius G. Nabavi, (unknown), Ludger Pientka, G.-M. von Reutern, E. Bernd Ringelstein, Dirk Sander, Markus Wagner, Klaus Berger	88
9	Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica--an ultrasonographic case-control study. 2005 ·PubMed ·K. Pfadenhauer, (unknown), Klaus Berger	23
10	Asymptomatic Carotid Atherosclerosis Is Associated With Circulating Chlamydia pneumoniae DNA in Younger Normotensive Subjects in a General Population Survey 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Rolf Mitusch, Jan Luedemann, W. G. Wood, Klaus Berger, Ulf Schminke, Matthias Suter, Christof Kessler, Ulrich John, Jan Rupp, M. Kentsch, Matthias Maass	9
11	Double-blind Crossover Trial of Trimethoprim-Sulfamethoxazole in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease 2001 ·Archives of Neurology ·Thorsten Schulte, (unknown), Klaus Berger, Sandra Szymanski, Peter Klotz, Peter H. Kraus, H. Przuntek, Lüdger Schöls	32
12	Light-to-Moderate Alcohol Consumption and the Risk of Stroke among U.S. Male Physicians 1999 ·New England Journal of Medicine ·Klaus Berger, Umed A. Ajani, Carlos S. Kase, J. Michael Gaziano, Julie E. Buring, Robert J. Glynn, Charles H. Hennekens	255
13	Hypertension and Borderline Isolated Systolic Hypertension Increase Risks of Cardiovascular Disease and Mortality in Male Physicians 1997 ·Circulation ·Christopher J. O’Donnell, Paul M. Ridker, Robert J. Glynn, Klaus Berger, Umed A. Ajani, JoAnn E. Manson, Charles H. Hennekens	132
14	Interobserver Agreement in the Classification of Stroke in the Physicians’ Health Study 1996 ·Stroke ·Klaus Berger, Carlos S. Kase, Julie E. Buring	59
15	Decompression of Portal Hypertension in a Child with Cystic Fibrosis after Transjugular Intrahepatic Portosystemic Shunt Placement 1994 ·Journal of Pediatric Gastroenterology and Nutrition ·Klaus Berger, Richard A. Schreiber, Jean Tchervenkov, Hinda Kopelman, (unknown), Lance L. Stein	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact